Table 2.
In-hospital events and treatment strategy of TTC patients according to sex difference
| Variables | Female (n=95) |
Male (n=19) |
P-value* |
|---|---|---|---|
| Life-threatening arrhythmia, n (%) | 10 (10.52) | 3 (15.78) | 0.45 |
| Mechanical respiratory support (NPPV and intubation), n (%) | 29 (30.52) | 10 (52.63) | 0.06 |
| Inotropic agents, n (%) | 15 (15.78) | 6 (31.57) | 0.10 |
| Resuscitation, n (%) | 6 (6.31) | 3 (15.78) | 0.17 |
| Defibrillator implantation, n (%) | 1 (1.05) | 0 (0) | 1.00 |
| VA-ECMO, n (%) | 0 (0) | 1 (5.2) | 1.00 |
| Admission to ICU, length of stay, mean ± SD | 4.14±6.39 | 5.94±5.73 | 0.26 |
| In-hospital death | 6 (6.31) | 3 (15.78) | 0.17 |
| Thromboembolic events | 13 (13.68) | 1 (5.26) | 0.45 |
| Acquired long QTs | 61 (64.21) | 12 (63.15) | 0.50 |
| Cardiogenic shock | 17 (17.89) | 5 (26.31) | 0.54 |
Note:
*
P-values for the comparison between female and male groups.
Abbreviations: TTC, Takotsubo cardiomyopathy; NPPV, non-invasive positive-pressure ventilation; VA-ECMO, venoarterial extracorporeal membrane oxygenation; ICU, intermediate care unit; SD, standard deviation.